Sotera Health Company (SHC)
USD 12.38
(2.31%)
USD 12.38
(2.31%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.68 Billion USD | -2.92% |
| 2022 | 2.76 Billion USD | 25.6% |
| 2021 | 2.2 Billion USD | -4.48% |
| 2020 | 2.3 Billion USD | -28.4% |
| 2019 | 3.22 Billion USD | 20.98% |
| 2018 | 2.66 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.63 Billion USD | 0.18% |
| 2024 Q1 | 2.63 Billion USD | -2.1% |
| 2024 Q3 | 2.67 Billion USD | 1.65% |
| 2023 Q4 | 2.68 Billion USD | 1.04% |
| 2023 Q2 | 2.65 Billion USD | -12.99% |
| 2023 Q1 | 3.05 Billion USD | 10.32% |
| 2023 Q3 | 2.65 Billion USD | 0.1% |
| 2023 FY | 2.68 Billion USD | -2.92% |
| 2022 Q3 | 2.2 Billion USD | 0.01% |
| 2022 FY | 2.76 Billion USD | 25.6% |
| 2022 Q4 | 2.76 Billion USD | 25.57% |
| 2022 Q2 | 2.2 Billion USD | 0.46% |
| 2022 Q1 | 2.19 Billion USD | -0.44% |
| 2021 Q3 | 2.21 Billion USD | -4.76% |
| 2021 Q4 | 2.2 Billion USD | -0.61% |
| 2021 FY | 2.2 Billion USD | -4.48% |
| 2021 Q1 | 2.31 Billion USD | 0.2% |
| 2021 Q2 | 2.32 Billion USD | 0.72% |
| 2020 Q2 | 3.24 Billion USD | 0.0% |
| 2020 FY | 2.3 Billion USD | -28.4% |
| 2020 Q3 | 3.36 Billion USD | 3.73% |
| 2020 Q4 | 2.3 Billion USD | -31.39% |
| 2020 Q1 | - USD | -100.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 3.22 Billion USD | 20.98% |
| 2019 Q4 | 3.22 Billion USD | 0.0% |
| 2018 FY | 2.66 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 40.22 Million USD | -6578.979% |
| Biodesix, Inc. | 94.51 Million USD | -2742.573% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -79711.318% |
| Castle Biosciences, Inc. | 86.54 Million USD | -3004.488% |
| DarioHealth Corp. | 38.24 Million USD | -6924.934% |
| Exact Sciences Corporation | 3.32 Billion USD | 19.222% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -51.329% |
| Illumina, Inc. | 4.36 Billion USD | 38.463% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -47913.643% |
| iSpecimen Inc. | 6.07 Million USD | -44103.019% |
| Standard BioTools Inc. | 159.86 Million USD | -1580.597% |
| 23andMe Holding Co. | 206.64 Million USD | -1200.133% |
| Medpace Holdings, Inc. | 1.09 Billion USD | -144.716% |
| NeoGenomics, Inc. | 739.69 Million USD | -263.217% |
| Inotiv, Inc. | 588.04 Million USD | -356.888% |
| Psychemedics Corporation | 6.59 Million USD | -40619.703% |
| Prenetics Global Limited | 44.01 Million USD | -6004.267% |
| Precipio, Inc. | 3.67 Million USD | -73066.83% |
| RadNet, Inc. | 2.07 Billion USD | -29.583% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -12295.322% |
| Exagen Inc. | 34.25 Million USD | -7744.339% |
| Natera, Inc. | 691.79 Million USD | -288.363% |
| Aspira Women's Health Inc. | 8.62 Million USD | -31042.761% |
| Neogen Corporation | 1.44 Billion USD | -86.573% |
| Myriad Genetics, Inc. | 312.9 Million USD | -758.64% |
| ICON Public Limited Company | 7.74 Billion USD | 65.329% |
| Bionano Genomics, Inc. | 118.24 Million USD | -2172.097% |
| CareDx, Inc | 223.28 Million USD | -1103.243% |
| Check-Cap Ltd. | 1.33 Million USD | -201906.466% |
| Twist Bioscience Corporation | 152.97 Million USD | -1656.337% |
| Guardant Health, Inc. | 1.62 Billion USD | -65.057% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -154135.189% |
| Fulgent Genetics, Inc. | 139.82 Million USD | -1821.491% |
| Sera Prognostics, Inc. | 25.28 Million USD | -10526.453% |
| OPKO Health, Inc. | 622.47 Million USD | -331.611% |
| Personalis, Inc. | 95.65 Million USD | -2708.637% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | -30502.979% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -12295.322% |
| MDxHealth SA | 121.92 Million USD | -2103.574% |
| Prenetics Global Limited | 44.01 Million USD | -6004.267% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -245224.278% |
| Mainz Biomed B.V. | 12.15 Million USD | -21994.817% |
| Trinity Biotech plc | 83.38 Million USD | -3122.064% |
| Neuronetics, Inc. | 81.64 Million USD | -3190.854% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -79711.318% |